Recombinant adeno-associated virus (rAAV) is a leading viral vector modality for gene therapy, with several approved treatments and hundreds of ongoing clinical trials. rAAV manufacturing, while ...
Tel Aviv University’s (TAU) new Translational Medical Research Center has acquired a VECTor PET/SPECT/CT to help bridge the gap between academic discoveries and new products that benefit patients. The ...
This proposal aims to develop an integrated, scalable, high-throughput recombinant adeno-associated virus (rAAV) screening and optimization platform to address the challenges associated with vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback